Date Time
Opportunity to join Team Australia at BIO
AusBiotech is inviting companies to be prominently profiled at its Team Australia digital pavilion at BIO Digital 2021. As the industry’s independent voice, AusBiotech has led the Australian delegation to BIO for more than a decade, and Australia’s strong presence will continue to be felt at BIO Digital 2021.
AusBiotech’s digital delegation showcases Australian capabilities, promotes the strength of the Australian life sciences, and fosters global connections with its overseas counterparts.
The strength of the Australian life sciences will be present, with strong Victorian and New South Wales partnerships profiled. Companies have the opportunity to align with these profiles or to take an overarching national presence.
This COVID-19 Vaccine Plant Shows Texas Is Becoming Biotech s Third Coast – Texas Monthly texasmonthly.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasmonthly.com Daily Mail and Mail on Sunday newspapers.
dani3315/Getty Images
CROP UPDATE: Gene editing offers significant potential benefits to all parts of agriculture, but the industry must bring the consumer along as part of the use of this new breeding tool. The rising of gene editing for crops creates opportunity, but early communication is critical to future success.
Gene editing has been in the news on and off a lot lately, whether it s the biography of the scientist who create a key tech making it possible, or news of the COVID-19 vaccines. But a burgeoning area of science is the use of this technology to enhance a wide range of crops; yet there are challenges to bringing the tools to market.
To embed, copy and paste the code into your website or blog:
In this episode of On Record PR, Sarah Larson goes on record with James Greenwood, senior policy advisor at DLA Piper, retired CEO of the Biotechnology Innovation Organization, and former congressman representing Bucks County, Pennsylvania.
Jim Greenwood started his career as a social worker focusing on abused and neglected children in 1980. At the age of 29, he was elected to the Pennsylvania House of Representatives and six years later to the state Senate. In 1992, he was elected to Congress and would go on to represent Pennsylvania’s eighth congressional district for six terms from 1993 to 2005. During his time in Congress, he was a senior member of the energy and commerce committee and widely viewed as a leader on healthcare and the environment. Jim crafted legislation to reform the Food and Drug Administration to create the pediatric exclusivity and pediatric autism research acts. And he led the fight in Congress t